[1]邹万芹,孙立军.地屈孕酮联合低分子肝素钙治疗先兆流产患者的效果[J].医学信息,2019,32(14):151-152.[doi:10.3969/j.issn.1006-1959.2019.14.050]
　ZOU Wan-qin,SUN Li-jun.Effect of Dydrogesterone Combined with Low Molecular Weight Heparin Calcium in Patients with Threatened Abortion[J].Journal of Medical Information,2019,32(14):151-152.[doi:10.3969/j.issn.1006-1959.2019.14.050]
点击复制

地屈孕酮联合低分子肝素钙治疗先兆流产患者的效果()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年14期
页码:
151-152
栏目:
药物与临床
出版日期:
2019-07-15

文章信息/Info

Title:
Effect of Dydrogesterone Combined with Low Molecular Weight Heparin Calcium in Patients with Threatened Abortion
文章编号:
1006-1959（2019）14-0151-02
作者:
邹万芹; 孙立军
天津市宝坻区妇产医院药剂科，天津 301800
Author(s):
ZOU Wan-qin; SUN Li-jun
Department of Pharmacy,Tianjin Baodi District Maternity Hospital,Tianjin 301800,China
关键词:
地屈孕酮; 联合治疗; 低分子肝素钙; 先兆流产; 临床效果
Keywords:
Key words：Dydrogesterone; Combination therapy; Low molecular weight heparin calcium; Threatened abortion; Clinical effect
分类号:
R714.21
DOI:
10.3969/j.issn.1006-1959.2019.14.050
文献标志码:
A
摘要:
目的 探讨地屈孕酮联合低分子肝素钙治疗先兆流产患者的效果。方法 选取2017年4月~2018年12月我院收治的先兆流产患者80例，按照随机数字表法分为对照组和研究组，各40例。对照组采用地屈孕酮进行治疗，研究组在对照组基础上联合低分子肝素钙进行治疗，比较两组妊娠结局及所产出新生儿不良结局。结果 研究组早产、流产、正常足月妊娠占比分别为12.50%、7.50%、80.00%，优于对照组的30.00%、17.50%、52.50，差异有统计学意义（P＜0.05）。研究组新生儿畸形、喘息急促、新生儿偏大、足月体重轻、正常新生儿占比分别为5.00%、10.00%、0、2.50%、82.50%，优于对照组的15.00%、22.50%、5.00%、10.00%、47.50%，差异有统计学意义（P＜0.05）。结论 地屈孕酮联合低分子肝素钙治疗先兆流产患者能够有效地改善患者的妊娠结局，减少新生儿畸形、喘息急促、新生儿偏大、足月体重轻等不良结局。
Abstract:
Abstract：Objective To investigate the effect of dydrogesterone combined with low molecular weight heparin calcium in the treatment of patients with threatened abortion.Methods 80 patients with threatened abortion admitted to our hospital from April 2017 to December 2018 were enrolled. The patients were divided into the control group and the study group according to the random number table method, 40 cases each. The control group was treated with dydrogesterone. The study group was treated with low molecular weight heparin calcium on the basis of the control group. The pregnancy outcomes of the two groups and the adverse outcomes of the newborns were compared.Results The preterm, abortion and normal term pregnancy proportions of the study group were 12.50%, 7.50%, and 80.00%, respectively, which were better than the control group's 30.00%, 17.50%, and 52.50,the difference was statistically significant (P<0.05), neonatal malformations, wheezing, neonatal hyperplasia, full-term weight, and normal neonatal proportions in the study group were 5.00%, 10.00%, 0, 2.50%, and 82.50%,15.00%, 22.50%, 5.00%, 10.00%, 47.50% better than the control group,the difference was statistically significant(P<0.05).Conclusion Dydrogesterone combined with low molecular weight heparin calcium in patients with threatened abortion can effectively improve the pregnancy outcome of patients, and reduce adverse outcomes such as neonatal malformation, wheezing, neonatal hyperplasia, and full-term weight.

参考文献/References:

[1]李慧,吴小妹,周玉华.低分子肝素钠联合地屈孕酮治疗先兆流产的临床观察[J].中国药房,2017,9(18):35-38. [2]李晓飞.低分子肝素钙联合地屈孕酮治疗对先兆流产患者妊娠结局的影响[J].内科,2017,12(5):674-676. [3]蔡志善,黄河.低剂量黄体酮注射液联合保胎无忧胶囊治疗先兆流产的疗效分析[J].中国药房,2017,25(6):241-243. [4]符星星,陶鑫焱,钟苑仪.低分子肝素治疗先兆流产的临床疗效观察[J].北方药学,2015(8):60-61. [5]彭金凤.先兆流产治疗中低分子肝素的应用效果分析[J].当代医学,2017,23(2):42-43.

相似文献/References:

[1]樊 艺,王亚飞.参芪寿胎汤联合地屈孕酮治疗先兆流产合并绒毛膜下出血的临床研究[J].医学信息,2018,31(24):123.[doi:10.3969/j.issn.1006-1959.2018.24.035]
　FAN Yi,WANG Ya-fei.Clinical Study of Shenqi Shoutai Decoction Combined with Dydrogesterone in the Treatment of Threatened Abortion with Submacular Hemorrhage[J].Journal of Medical Information,2018,31(14):123.[doi:10.3969/j.issn.1006-1959.2018.24.035]
[2]阿小英.阿司匹林联合地屈孕酮治疗习惯性流产患者的效果及对凝血、免疫功能的影响[J].医学信息,2020,33(19):138.[doi:10.3969/j.issn.1006-1959.2020.19.042]
　A Xiao-ying.The Effect of Aspirin Combined with Dydrogesterone in the Treatment of Patients with Habitual Abortion and Its Influence on Blood Coagulation and Immune Function[J].Journal of Medical Information,2020,33(14):138.[doi:10.3969/j.issn.1006-1959.2020.19.042]
[3]程 杰,王士杰,孙寒蕾.Vitapex及AH plus糊剂联合应用治疗牙周牙髓联合病变的临床观察[J].医学信息,2023,36(02):138.[doi:10.3969/j.issn.1006-1959.2023.02.029]
　CHENG Jie,WANG Shi-jie,SUN Han-lei.Clinical Observation of Vitapex Combined with AH Plus Paste in the Treatment of Combined Periodontal-endodontic Lesions[J].Journal of Medical Information,2023,36(14):138.[doi:10.3969/j.issn.1006-1959.2023.02.029]
[4]孙 睿.地屈孕酮联合来曲唑对子宫内膜异位症患者性激素及CA125水平的影响[J].医学信息,2021,34(20):164.[doi:10.3969/j.issn.1006-1959.2021.20.044]
　SUN Rui.The Effect of Dydrogesterone Combined with Letrozole on the Levels of Sex Hormones andCA125 in Patients with Endometriosis[J].Journal of Medical Information,2021,34(14):164.[doi:10.3969/j.issn.1006-1959.2021.20.044]
[5]邵景萍.曼月乐与地屈孕酮治疗围绝经期异常子宫出血的疗效及对性激素水平的影响[J].医学信息,2022,35(07):165.[doi:10.3969/j.issn.1006-1959.2022.07.043]
　SHAO Jing-ping.Efficacy of Mirena and Dydrogesterone in the Treatment of Perimenopausal Abnormal Uterine Bleeding and its Effect on Sex Hormone Levels[J].Journal of Medical Information,2022,35(14):165.[doi:10.3969/j.issn.1006-1959.2022.07.043]

更新日期/Last Update: 2019-07-15